Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Mem. Inst. Oswaldo Cruz ; 96(suppl): 157-164, Sept. 2001. tab
Article in English | LILACS | ID: lil-295894

ABSTRACT

Praziquantel was given every eight weeks for two years to children aged under six years of age, living in a Schistosoma haematobium endemic area. Infection with S. haematobium and haematuria were examined in urine and antibody profiles (IgA, IgE, IgM, IgG1, IgG2, IgG3, and IgG4) against S. haematobium adult worm and egg antigens were determined from sera collected before each treatment. Chemotherapy reduced infection prevalence and mean intensity from 51.8 percent and 110 eggs per 10 ml urine, respectively, before starting re-treatment programme to very low levels thereafter. Praziquantel is not accumulated after periodic administration in children. Immunoglobulin levels change during the course of treatment with a shift towards 'protective' mechanisms. The significant changes noted in some individuals were the drop in 'blocking' IgG2 and IgG4 whereas the 'protecting' IgA and IgG1 levels increased. The antibody profiles in the rest of the children remained generally unchanged throughout the study and no haematuria was observed after the second treatment. The removal of worms before production of large number of eggs, prevented the children from developing morbidity


Subject(s)
Humans , Animals , Child , Anthelmintics/therapeutic use , Praziquantel/therapeutic use , Schistosomiasis haematobia/drug therapy , Antibodies, Helminth/isolation & purification , Antigens, Helminth/isolation & purification , Endemic Diseases , Follow-Up Studies , Hematuria/immunology , Recurrence , Retreatment , Schistosoma haematobium/immunology , Schistosomiasis haematobia/epidemiology , Schistosomiasis haematobia/immunology , Time Factors , Zimbabwe/epidemiology
2.
Mem. Inst. Oswaldo Cruz ; 96(suppl): 89-101, Sept. 2001. ilus, graf, tab
Article in English | LILACS | ID: lil-295895

ABSTRACT

T cell clones were derived from peripheral blood mononuclear cells of Schistosoma haematobium infected and uninfected individuals living in an endemic area. The clones were stimulated with S. haematobium worm and egg antigens and purified protein derivative. Attempts were made to classify the T cell clones according to production of the cytokines IL-4, IL-5 and IFN-gamma. All the T cell clones derived were observed to produce cytokines used as markers for the classification of Th1/Th2 subsets. However, the 'signature' cytokines marking each subset were produced at different levels. The classification depended on the dominating cytokine type, which was having either Th0/1 or Th0/2 subsets. The results indicated that no distinct cytokine profiles for polarisation of Th1/Th2 subsets were detected in these S. haematobium infected humans. The balance in the profiles of cytokines marking each subset were related to infection and re-infection status after treatment with praziquantel. In the present study, as judged by the changes in infection status with time, the T cell responses appeared to be less stable and more dynamic, suggesting that small quantitative changes in the balance of the cytokines response could result in either susceptibility or resistant to S. haematobium infection


Subject(s)
Humans , Animals , Child , Cytokines/biosynthesis , Schistosoma haematobium/immunology , Schistosomiasis haematobia/immunology , T-Lymphocytes, Helper-Inducer/classification , Anthelmintics/therapeutic use , Antigens, Helminth , Cell Line , Clone Cells/classification , Clone Cells/metabolism , Cytokines/analysis , Cytokines/isolation & purification , Enzyme-Linked Immunosorbent Assay , Follow-Up Studies , Parasite Egg Count , Praziquantel/therapeutic use , Schistosomiasis haematobia/drug therapy , T-Lymphocyte Subsets/classification , T-Lymphocyte Subsets/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , Th1 Cells/classification , Th1 Cells/metabolism , Th2 Cells/classification , Th2 Cells/metabolism , Titrimetry
3.
Mem. Inst. Oswaldo Cruz ; 92(supl.2): 45-54, Dec. 1997. ilus, tab, graf
Article in English | LILACS | ID: lil-202014

ABSTRACT

Eosinophils have long been thought to be effectors of immunity to helminth but have also been implicated in the pathogenesis of asthma. Patterns of cytokine production in the host may influence the pathogenesis of these diseases by regulating the activities of eosinophils and other components of the immune response. Mice which constitutively over-express IL-5 have profound and life-long eosinophilia in a restricted number of tissues. Although eosinophils from IL-5 transgenics are funtionally competent for a number of parameters considered to be important in inflammation, untreated animals are overtly normal and free of disease. In addition, the responses of these animals when exposed to aeroallergens and helminth present a number of apparent paradoxes. Eosinophil accumulation in tissue adjacent to major airways is rapid and extensive in transgenics exposed to the aeroallergen, but even after treatment with antigen over many months these mice show no evidence of respiratory distress or pathology. Helminth-infected IL-5 transgenics and their non-transgenic littermates develop similar inflammatory responses at mucosal sites and are comparable for a number of T cell and antibody responses, but they differ considerably in their ability to clear some parasite species. The life-cycle of Nippostrongylus brasilensis is significantly inhibited in IL-5 transgenics, but that of Toxocara canis is not. Our results suggest that eosinophilia and/or over-expression of IL-5 may actually impair host resistance to Schistosoma mansoni and Trichinella spiralis. The pathogenesis of diseases in which eosinophils are involved may therefore be more complex than previously thought.


Subject(s)
Animals , Mice , Asthma/immunology , Mice, Transgenic/immunology , Helminths/immunology , Respiratory Hypersensitivity/immunology , Interleukin-4/immunology , Eosinophils/pathology , Nippostrongylus/immunology , Schistosoma mansoni/immunology , Toxocara canis/immunology , Trichinella spiralis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL